GB9917995D0 - Polypeptide - Google Patents
PolypeptideInfo
- Publication number
- GB9917995D0 GB9917995D0 GBGB9917995.4A GB9917995A GB9917995D0 GB 9917995 D0 GB9917995 D0 GB 9917995D0 GB 9917995 A GB9917995 A GB 9917995A GB 9917995 D0 GB9917995 D0 GB 9917995D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (26)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9917995.4A GB9917995D0 (en) | 1999-07-30 | 1999-07-30 | Polypeptide |
EP09000205A EP2042598A1 (en) | 1998-11-18 | 1999-11-18 | 5T4 tumour-associated antigen for use in tumour immunotherapy |
EP99972219A EP1036091B2 (en) | 1998-11-18 | 1999-11-18 | 5t4 tumour-associated antigen for use in tumour immunotherapy |
PCT/GB1999/003859 WO2000029428A2 (en) | 1998-11-18 | 1999-11-18 | 5t4 tumour-associated antigen for use in tumour immunotherapy |
AU13949/00A AU766954B2 (en) | 1998-11-18 | 1999-11-18 | Polypeptide |
CA002351622A CA2351622A1 (en) | 1998-11-18 | 1999-11-18 | Polypeptide |
KR1020017006155A KR20010084935A (en) | 1998-11-18 | 1999-11-18 | Polypeptide |
GB0127673A GB2370572B (en) | 1998-11-18 | 1999-11-18 | Use of a professional antigen presenting cell |
DE69924826T DE69924826T8 (en) | 1998-11-18 | 1999-11-18 | USE OF CANCER ASSOCIATED ANTIGEN 5T4 TO IMMUNE THERAPY |
GB0014986A GB2347932B (en) | 1998-11-18 | 1999-11-18 | Vectors for the delivery of 5T4 antigen |
EP01201448A EP1160323A1 (en) | 1998-11-18 | 1999-11-18 | 5T4 tumour-associated antigen for use in tumour immunotherapy |
EP01201447.8A EP1152060B1 (en) | 1998-11-18 | 1999-11-18 | 5T4 tumour-associated antigen for use in tumour immunotherapy |
CNB998156329A CN1298851C (en) | 1998-11-18 | 1999-11-18 | Polypeptide |
GB0224538A GB2378704B (en) | 1998-11-18 | 1999-11-18 | Uses of 5t4 antigen |
GB0127675A GB2370573A (en) | 1998-11-18 | 1999-11-18 | Poxviral vectors |
CN 200610168977 CN101134102B (en) | 1998-11-18 | 1999-11-18 | 5T4 antigen-expressed vector |
JP2000582415A JP4907767B2 (en) | 1998-11-18 | 1999-11-18 | Polypeptide |
GB0127669A GB2370571B (en) | 1998-11-18 | 1999-11-18 | A modified 5t4 antigen |
AT99972219T ATE293690T1 (en) | 1998-11-18 | 1999-11-18 | USE OF CANCER-ASSOCIATED ANTIGEN 5T4 FOR IMMUNOTHERAPY |
US09/533,798 US7148035B1 (en) | 1998-11-18 | 2000-03-24 | Polypeptide |
US10/774,176 US20040265275A1 (en) | 1998-11-18 | 2004-02-06 | Polypeptide |
US11/286,056 US7601698B2 (en) | 1998-11-18 | 2005-11-22 | Polypeptide |
US11/456,530 US20090191230A1 (en) | 1998-11-18 | 2006-07-10 | Cascade |
US11/532,816 US7666669B2 (en) | 1998-11-18 | 2006-09-18 | Polypeptide |
US11/686,793 US7615612B2 (en) | 1998-11-18 | 2007-03-15 | Polypeptide |
US12/637,350 US20100233126A1 (en) | 1998-11-18 | 2009-12-14 | Polypeptide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9917995.4A GB9917995D0 (en) | 1999-07-30 | 1999-07-30 | Polypeptide |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9917995D0 true GB9917995D0 (en) | 1999-09-29 |
Family
ID=10858286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9917995.4A Ceased GB9917995D0 (en) | 1998-11-18 | 1999-07-30 | Polypeptide |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB9917995D0 (en) |
-
1999
- 1999-07-30 GB GBGB9917995.4A patent/GB9917995D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0128994D0 (en) | Peptides | |
GB9923177D0 (en) | Novel polypeptide | |
GB9921125D0 (en) | Proteins | |
EP1197556A4 (en) | Useful polypeptide | |
GB9923889D0 (en) | Novel polypeptide | |
EP1147130A4 (en) | Alpha-conotoxin peptides | |
EP1162269A4 (en) | Novel polypeptide | |
GB9904695D0 (en) | Peptide | |
EP1159288A4 (en) | Alpha-conotoxin peptides | |
GB9924951D0 (en) | Novel polypeptide | |
EP1179540A4 (en) | Novel polypeptide | |
GB9908920D0 (en) | Peptide | |
GB9903408D0 (en) | Peptides | |
HK1045173A1 (en) | Polypeptide | |
GB9923890D0 (en) | Novel polypeptide | |
GB9923893D0 (en) | Novel polypeptide | |
GB9920000D0 (en) | Polypeptides | |
GB9923888D0 (en) | Novel polypeptide | |
GB9925115D0 (en) | Novel polypeptide | |
GB9924960D0 (en) | Novel polypeptide | |
GB9918680D0 (en) | Polypeptide | |
EP1151100A4 (en) | Tau-conotoxin peptides | |
GB9924956D0 (en) | Novel polypeptide | |
IL149355A0 (en) | Polypeptide corporation | |
GB9901739D0 (en) | Polypeptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |